Literature DB >> 25697840

Consumers' perception of generic substitution in Iran.

Nazila Yousefi1, Gholamhossein Mehralian, Farzad Peiravian, Samaneh NourMohammadi.   

Abstract

BACKGROUND: The growth of pharmaceutical expenditure and patients' out of pocket has motivated policy makers to encourage patients to substitution of brands medicines with their generic alternatives called generic substitution.
OBJECTIVES: As the patients are final decision makers to accept generic substitution, the aim of this study is to evaluate the patient perception about generic medicines and underlying factors which can promote the generic acceptance.
SETTING: The study was done in community pharmacies in Tehran, the capital city of Iran.
METHOD: A cross-sectional descriptive study inviting people purchasing their drug at community pharmacies were per-formed using a self-administrated anonymous questionnaire (N=1309). MAIN OUTCOMES MEASURES: Besides the demographic section, 16 items of developed questionnaire were categorized to five main factors including: patients' perception about efficiency, safety and cost of generic medicines, patient trust on physicians and pharmacists' advice.
RESULTS: Findings of completed questionnaires showed among the aforementioned factors the physician has the first priority to encourage patients to use of generics medicines which followed respectively by pharmacist's role, cost of medicines, efficacy, and safety concerns.
CONCLUSION: In conclusion, the trust of Iranian's society on the physicians and pharmacists advice would create a credible opportunity to reduce pharmaceutical expenditures as well as patients' out of pocket by promotion of generic substitution.

Entities:  

Mesh:

Year:  2015        PMID: 25697840     DOI: 10.1007/s11096-015-0085-4

Source DB:  PubMed          Journal:  Int J Clin Pharm


  30 in total

1.  Patients' attitudes towards and experiences of generic drug substitution in Norway.

Authors:  Inge Kjoenniksen; Morten Lindbaek; Anne Gerd Granas
Journal:  Pharm World Sci       Date:  2006-11-17

2.  Trade, TRIPS, and pharmaceuticals.

Authors:  Richard D Smith; Carlos Correa; Cecilia Oh
Journal:  Lancet       Date:  2009-01-21       Impact factor: 79.321

3.  Switching from originator brand medicines to generic equivalents in selected developing countries: how much could be saved?

Authors:  Alexandra Cameron; Aukje K Mantel-Teeuwisse; Hubert G M Leufkens; Richard Ogilvie Laing
Journal:  Value Health       Date:  2012-07-11       Impact factor: 5.725

4.  An evaluation of consumers' knowledge, perceptions and attitudes regarding generic medicines in Auckland.

Authors:  Zaheer-Ud-Din Babar; Joanna Stewart; Shiwangni Reddy; Woroud Alzaher; Prateeka Vareed; Nineweh Yacoub; Bandhana Dhroptee; Anne Rew
Journal:  Pharm World Sci       Date:  2010-06-18

5.  Impact of the Minimum Pricing Policy and introduction of brand (generic) substitution into the Pharmaceutical Benefits Scheme in Australia.

Authors:  P McManus; D J Birkett; J Dudley; A Stevens
Journal:  Pharmacoepidemiol Drug Saf       Date:  2001 Jun-Jul       Impact factor: 2.890

6.  People's views on the level of agreement of generic medicines for different illnesses.

Authors:  Maria João Figueiras; Dália Marcelino; Maria Armanda Cortes
Journal:  Pharm World Sci       Date:  2008-08-14

7.  Price, familiarity, and availability determine the choice of drug - a population-based survey five years after generic substitution was introduced in Finland.

Authors:  Pekka Mäntyselkä; Riitta Ahonen; Reeta Heikkilä
Journal:  BMC Clin Pharmacol       Date:  2011-12-15

8.  A qualitative evaluation of general practitioners' perceptions regarding access to medicines in New Zealand.

Authors:  Zaheer-Ud-Din Babar; Piyush Grover; Rachael Butler; Lynne Bye; Janie Sheridan
Journal:  BMJ Open       Date:  2012-03-28       Impact factor: 2.692

9.  Evaluating patients' perceptions regarding generic medicines in Jordan.

Authors:  Faris El-Dahiyat; Reem Kayyali
Journal:  J Pharm Policy Pract       Date:  2013-06-13

10.  Knowledge, Attitude and Practice of Pharmacists regarding Dietary Supplements : A Community Pharmacy- based survey in Tehran.

Authors:  Gholamhossein Mehralian; Nazila Yousefi; Farshad Hashemian; Hanieh Maleksabet
Journal:  Iran J Pharm Res       Date:  2014       Impact factor: 1.696

View more
  6 in total

1.  Perceptions and behaviors of patients and pharmacists towards generic drug substitution in Lebanon.

Authors:  Shadi Saleh; Clara Abou Samra; Stewart Jleilaty; Joanne Constantin; Nour El Arnaout; Hani Dimassi; Dania Al-Bittar
Journal:  Int J Clin Pharm       Date:  2017-08-19

2.  A nationwide survey exploring physicians' and pharmacists' knowledge, awareness and perceptions regarding generic medicines in China.

Authors:  Jinghan Qu; Wei Zuo; Roxane L Took; Kenneth W Schafermeyer; Stephanie Lukas; Shaohong Wang; Liping Du; Xin Liu; Yang Gao; Jiantao Li; Hui Pan; Xiaoli Du; Dan Mei; Bo Zhang
Journal:  BMC Health Serv Res       Date:  2022-08-20       Impact factor: 2.908

3.  Factors facilitating and hindering counselling about generic substitution and a reference price system in community pharmacies - a survey among Finnish dispensers.

Authors:  Riikka Rainio; Riitta Ahonen; Elina Lämsä; Johanna Timonen
Journal:  BMC Health Serv Res       Date:  2022-09-07       Impact factor: 2.908

Review 4.  Perceptions of generic medication in the general population, doctors and pharmacists: a systematic review.

Authors:  Sarah Colgan; Kate Faasse; Leslie R Martin; Melika H Stephens; Andrew Grey; Keith J Petrie
Journal:  BMJ Open       Date:  2015-12-15       Impact factor: 2.692

5.  Factors influencing the preference for purchasing generic drugs in a Southern Brazilian city.

Authors:  Marília Cruz Guttier; Marysabel Pinto Telis Silveira; Vera Lucia Luiza; Andréa Dâmaso Bertoldi
Journal:  Rev Saude Publica       Date:  2017-06-26       Impact factor: 2.106

6.  The content of patient counseling about interchangeable medicines and generic substitution in Finnish community pharmacies - a survey of dispensers.

Authors:  Riikka Rainio; Riitta Ahonen; Johanna Timonen
Journal:  BMC Health Serv Res       Date:  2019-12-11       Impact factor: 2.655

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.